Thus, while ARG1/AGMAT expression modulates arginine abundance and tumour growth in liver cancer, there appears to be additional metabolic complexity regarding the sources and sinks of arginine to be parsed in future work. The gene discussed is AGMAT; the disease is liver cancer.